MORGAN STANLEY PLC/PUT/ABBOTT LABORATORIES/100/0.1/20.06.25 Stock

Warrant

DE000MB71RE5

Market Closed - Börse Stuttgart 12:54:48 2024-07-05 EDT
0.6 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/PUT/ABBOTT LABORATORIES/100/0.1/20.06.25
Current month+16.67%
1 month+6.78%
Date Price Change
24-07-05 0.63 +5.00%
24-07-04 0.6 -4.76%
24-07-03 0.63 +5.00%
24-07-02 0.6 0.00%
24-07-01 0.6 +11.11%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 12:54 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MB71RE
ISINDE000MB71RE5
Date issued 2023-06-06
Strike 100 $
Maturity 2025-06-20 (349 Days)
Parity 10 : 1
Emission price 1.02
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.53
Lowest since issue 0.36
Delta-0.35x
Omega 5.808
Premium9.73x
Gearing16.67x
Moneyness 0.9627
Difference Strike -4.02 $
Difference Strike %-4.02%
Spread 0.01
Spread %1.72%
Theoretical value 0.5750
Implied Volatility 23.38 %
Total Loss Probability 57.55 %
Intrinsic value 0.000000
Present value 0.5750
Break even 93.77 €
Theta-0.01x
Vega0.03x
Rho-0.03x

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
124.9 USD
Spread / Average Target
+20.09%
Consensus